Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × Cancer Pain × Naloxone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 3 Cancer Pain 2

Interventions

Oxycodone 9 Fentanyl 4 Morphine 3 Ethanol 3 Naloxone 2 Buprenorphine 2 Acetaminophen 2 rofecoxib 1 Ultracet 1 Radiofrequency Ablation 1 Polyethylene Glycols 1 Methadone 1 Magnesium Hydroxide 1 Electrolytes 1 Duration of Therapy 1 Dosage Forms 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01313780 2017-12-22

TOP

Mundipharma Korea Ltd

Phase 4 Completed

128 enrolled 8 charts

Cancer Pain, Neoplasms

NCT01719757 2016-08-19

PROBE

Mundipharma Korea Ltd

Phase 4 Completed

359 enrolled 10 charts

Cancer Pain, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡